RE: EBITDA of $6-million for Q3/2020 - ZenabisZenabis continued to implement significant cost-cutting measures, resulting in an overall 31-per-cent increase in adjusted EBITDA and a significant increase in the gross margin on net revenue in the cannabis segment for Q2/2020.
For Q3, growth in net cannabis revenue of 78 per cent will result in EBITDA of $6-million for the quarter.